Benjamin Edwards Inc Intellia Therapeutics, Inc. Transaction History

Benjamin Edwards Inc

  • $6.71 Billion
  • Q3 2024

A detailed history of Benjamin Edwards Inc transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Benjamin Edwards Inc holds 57,669 shares of NTLA stock, worth $588,223. This represents 0.02% of its overall portfolio holdings.

Number of Shares
57,669
Previous 416 13762.74%
Holding current value
$588,223
Previous $9,000 13066.67%
% of portfolio
0.02%
Previous 0.0%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$19.72 - $27.36 $1.13 Million - $1.57 Million
57,253 Added 13762.74%
57,669 $1.19 Million
Q2 2024

Aug 12, 2024
SELL
$20.02 - $27.22 $2,922 - $3,974
-146 Reduced 25.98%
416 $9,000
Q1 2024

Apr 29, 2024
BUY
$23.82 - $32.8 $833 - $1,148
35 Added 6.64%
562 $15,000
Q4 2023

Feb 06, 2024
SELL
$23.16 - $32.34 $7,341 - $10,251
-317 Reduced 37.56%
527 $16,000
Q3 2023

Nov 13, 2023
BUY
$31.62 - $45.78 $2,466 - $3,570
78 Added 10.18%
844 $27,000
Q2 2023

Aug 15, 2023
BUY
$34.58 - $46.03 $622 - $828
18 Added 2.41%
766 $31,000
Q1 2023

Apr 27, 2023
BUY
$33.3 - $44.82 $1,265 - $1,703
38 Added 5.35%
748 $28,000
Q4 2022

Feb 07, 2023
BUY
$33.21 - $62.69 $4,682 - $8,839
141 Added 24.78%
710 $25,000
Q3 2022

Oct 28, 2022
SELL
$53.92 - $71.7 $2,372 - $3,154
-44 Reduced 7.18%
569 $32,000
Q2 2022

Aug 12, 2022
BUY
$38.49 - $76.21 $230 - $457
6 Added 0.99%
613 $32,000
Q1 2022

May 04, 2022
SELL
$58.27 - $118.99 $4,719 - $9,638
-81 Reduced 11.77%
607 $44,000
Q4 2021

Feb 07, 2022
BUY
$100.76 - $138.36 $3,627 - $4,980
36 Added 5.52%
688 $81,000
Q3 2021

Nov 02, 2021
SELL
$132.37 - $176.78 $26,209 - $35,002
-198 Reduced 23.29%
652 $87,000
Q2 2021

Aug 11, 2021
SELL
$60.88 - $161.91 $26,969 - $71,726
-443 Reduced 34.26%
850 $138,000
Q1 2021

May 14, 2021
SELL
$46.59 - $83.68 $372 - $669
-8 Reduced 0.61%
1,293 $104,000
Q4 2020

Feb 16, 2021
SELL
$18.83 - $63.53 $11,166 - $37,673
-593 Reduced 31.31%
1,301 $71,000
Q3 2020

Nov 16, 2020
BUY
$17.47 - $24.93 $1,345 - $1,919
77 Added 4.24%
1,894 $38,000
Q1 2020

May 07, 2020
SELL
$9.44 - $15.58 $575 - $950
-61 Reduced 3.25%
1,817 $22,000
Q4 2019

Feb 06, 2020
BUY
$10.43 - $17.67 $2,325 - $3,940
223 Added 13.47%
1,878 $28,000
Q3 2019

Nov 05, 2019
SELL
$13.07 - $18.51 $470 - $666
-36 Reduced 2.13%
1,655 $22,000
Q2 2019

Aug 08, 2019
BUY
$13.88 - $18.41 $8,883 - $11,782
640 Added 60.89%
1,691 $28,000
Q1 2019

May 15, 2019
BUY
$12.79 - $17.62 $13,442 - $18,518
1,051 New
1,051 $18,000

Others Institutions Holding NTLA

# of Institutions
314
Shares Held
91.5M
Call Options Held
442K
Put Options Held
880K
View Full List

About Intellia Therapeutics, Inc.

NTLA Quotes by TradingView
  • Ticker NTLA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 76,011,800
  • Market Cap $775M
  • Description
  • Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...
More about NTLA
Track This Portfolio

Track Benjamin Edwards Inc Portfolio

Follow Benjamin Edwards Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Benjamin Edwards Inc, based on Form 13F filings with the SEC.

News

Stay updated on Benjamin Edwards Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email